TY  - GEN
AU  - Benkerrou,M
AU  - Jais,J P
AU  - Leblond,V
AU  - Durandy,A
AU  - Sutton,L
AU  - Bordigoni,P
AU  - Garnier,J L
AU  - Le Bidois,J
AU  - Le Deist,F
AU  - Blanche,S
AU  - Fischer,A
TI  - Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome
SN  - 0006-4971
PY  - 1998///1130
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Animals
KW  - Antibodies, Monoclonal
KW  - immunology
KW  - Antibodies, Neoplasm
KW  - Antibody Specificity
KW  - Antigens, CD
KW  - Antigens, Neoplasm
KW  - B-Lymphocytes
KW  - CD24 Antigen
KW  - Child
KW  - Child, Preschool
KW  - Clone Cells
KW  - Cohort Studies
KW  - Epstein-Barr Virus Infections
KW  - Female
KW  - Humans
KW  - Immunization, Passive
KW  - Immunosuppression Therapy
KW  - adverse effects
KW  - Infant
KW  - Lymphoproliferative Disorders
KW  - etiology
KW  - Male
KW  - Membrane Glycoproteins
KW  - Mice
KW  - Middle Aged
KW  - Prognosis
KW  - Receptors, Complement 3d
KW  - Remission Induction
KW  - Risk Factors
KW  - Survival Analysis
KW  - Transplantation
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
ER  -